At birth, an infant’s immune system is complete but immature. A newborn baby’s immune system will be exposed to large numbers of microorganisms, viruses and foreign proteins which will develop and strengthen its powers of resistance. This process is supported by components in milk that help the infant via a number of advanced and complex biological mechanisms.
One of our products, Lacprodan® OPN (osteopontin), influences the regulation of the innate and adaptive immune system. This bioactive component is found in high amounts in human milk and could be a significant missing link in producing infant formula with the ability to deliver immune protection similar to human milk.
Another of our products having effects within this area is Lacprodan® MFGM-10 which have a unique protein and lipid profile including bioactive compounds such as lactoferrin, IgG and phospholipids including gangliosides. This composition is behind antiviral and antibacterial mechanisms that combat gut-derived infections.
Related products: Lacprodan® OPN-10 and Lacprodan® MFGM-10.
Zavaleta et al. 2011. J Pediatr Gastroenterol Nutr. 53: 561-568.
Lönnerdal et al. 2016. J Pediatr Gastroenterol Nutr. 62: 650-657
Using infant formulas is second to breastfeeding, a fact supported by WHO. This information is for professional use only.